Sector
PharmaceuticalsOpen
₹111Prev. Close
₹109.71Turnover(Lac.)
₹367.58Day's High
₹113.44Day's Low
₹110.0852 Week's High
₹18652 Week's Low
₹68.72Book Value
₹157.03Face Value
₹10Mkt Cap (₹ Cr.)
677.42P/E
7.54EPS
14.8Divi. Yield
020 Jan 2025
12:00 AM
EGM
2 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
23 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 59.09 | 59.81 | 59.81 | 59.81 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 863.16 | 615.54 | 572.75 | 578.89 |
Net Worth | 922.25 | 675.35 | 632.56 | 638.7 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 856.57 | 751.83 | 731.29 | 693.71 |
yoy growth (%) | 13.93 | 2.8 | 5.41 | 8.6 |
Raw materials | -424.99 | -378.84 | -375.06 | -395.81 |
As % of sales | 49.61 | 50.38 | 51.28 | 57.05 |
Employee costs | -104.16 | -100.37 | -89.3 | -71.61 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 16.11 | -19.56 | 30.51 | -50.85 |
Depreciation | -87.29 | -90.05 | -86.61 | -88.25 |
Tax paid | -20.51 | -1.22 | -10.95 | 16.46 |
Working capital | 24.4 | 224.01 | -12.39 | -206.93 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 13.93 | 2.8 | 5.41 | 8.6 |
Op profit growth | 27.14 | 11.71 | 20.97 | -3.11 |
EBIT growth | 32.31 | 49.44 | 56.9 | -0.94 |
Net profit growth | -78.84 | -217.94 | -144.36 | -32.51 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 1,280.9 | 1,207.31 | 1,038.73 | 891.34 | 779.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,280.9 | 1,207.31 | 1,038.73 | 891.34 | 779.64 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 431.96 | 33.5 | 43.5 | 22.7 | 33.4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,687.6 | 94.57 | 4,05,007.74 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,658 | 80.01 | 1,76,747.65 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,502.4 | 25.22 | 1,21,378.29 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,341.4 | 59.4 | 1,13,184.61 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,301 | 20.3 | 1,08,591.61 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
N R Munjal
Joint Managing Director
Himanshu Jain
Company Sec. & Compli. Officer
Pradeep Verma
Executive Director
Rishav Mehta
Independent Director
S P Sharma
Independent Director
Neerja Chathley
Independent Director
Ashwani K Vig
Executive Director
Sahil Munjal
Independent Director
Rajendra Kumar Gupta
Independent Director
Param Bir Singh
SCO 850 Shivalik Enclave,
NAC Manimajra,
Chandigarh - 160101
Tel: 91-0172-5061850/2730920
Website: http://www.indswiftlabs.com
Email: investor@indswiftlabs.com, info@indswiftlabs.com
205/208,
Anarkali Market, Jhandewalan Extn,
New Delhi - 110055
Tel: 91-011-42541965/4254
Website: www.alankit.com
Email: info@alankit.com
Summary
Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, India. The Company is one of the leading manufacturers of APIs catering to global and domestic formulators. ...
Read More
Reports by Ind-Swift Laboratories Ltd
What is the Ind-Swift Laboratories Ltd share price today?
What is the Market Cap of Ind-Swift Laboratories Ltd?
What is the PE and PB ratio of Ind-Swift Laboratories Ltd?
What is the 52 Week High and Low of Ind-Swift Laboratories Ltd?
What is the CAGR of Ind-Swift Laboratories Ltd?
What is the shareholding pattern of Ind-Swift Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.